Evotec (NASDAQ:EVO) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 16.67 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $191.620 million which missed the analyst consensus estimate of $237.320 million by 19.26 percent. This is a 5.71 percent decrease over sales of $203.214 million the same period last year.